Remote Patient Monitoring Software And Services Market Size, Share | Report 2022-2030
Remote patient monitoring allows the healthcare professionals to monitor disease and symptom progression remotely andengage with patients virtually to modify the care plans and provide education on self-care, based on changes in the patient’s condition. The increasing adoption of remote patient monitoring as it helps in the management of chronic disease and contributes to reducing the frequency of hospital admissions and lowers the healthcare cost thereby driving the market growth. In addition, the RPM software facilitates patient engagement by allowing the patients to connect with the care team 24/7 and provides the patients greater control over their health by providing time-to-time reminders. Also, it helps patients to manage a balanced health status at every point-of-care cycle from arising concerns, preliminary diagnosis, and quick treatment to post-discharge recovery.In addition,the outbreak of COVID-19 prompted a significant increase in the interaction of healthcare professionals with patients through RPM solutions, which allowed for continued access to timely and needed care.
The increasing digitalization and rising penetration of the internet across the globe are some of the factors impelling the market. Furthermore, rising healthcare costs and the growing need to monitor population health in real-time & accurately is supporting the adoption of RPM software solutions and applications. Also, the shift to value-based care models in developed economies and several initiatives by public & private players to further develop various applications and software for remote patient monitoring is expected to drive the segment.
The market players focusing on the development of software specifically used for various diseases such as diabetes, cancer, and cardiovascular disease among others is further fuelling the adoption of the software. For instance, The Dexcom Clarity software specifically tracks trends in blood glucose gleaned from the wearable device and provides the patient with a visual analysis of the data. Moreover, the government initiatives to support the facilitation of remote patient monitoring software are boosting the market. For instance, the U.S. FDA issued several guidelines for utilizing RPM software to facilitate the management of patients. Also, in March 2020, the U.S. Congress announced a mandatory funding authorization for USD 500 Million over 10 years to be used towards a remote healthcare program, thereby showinginterest in expanding RPM across health care institutions.
Some of the key players in the market are Medtronic Plc., GE Healthcare, Siemens Healthineers AG, Philips Healthcare, Caretaker Medical, OMRON Healthcare, and BioIntelliSense. Various strategies such as product launch, collaborations, merger and acquisitions are adopted by these key players to increase the market share. For instance, in January 2021, OMRON Healthcare introduced ‘VitalSight’, its first remote patient monitoring service andpreviewed a new app, which will increase the capabilities of every OMRON connected blood pressure monitor.
Market Segmentation
By Type Outlook
By Application Outlook
By End- Use Outlook
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Remote Patient Monitoring Software And Services Market
5.1. COVID-19 Landscape: Remote Patient Monitoring Software And Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Remote Patient Monitoring Software And Services Market, By Type
8.1. Remote Patient Monitoring Software And Services Market, by Type, 2022-2030
8.1.1 Software
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Remote Patient Monitoring Software And Services Market, By Application
9.1. Remote Patient Monitoring Software And Services Market, by Application, 2022-2030
9.1.1. Cancer
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Cardiovascular disease
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Diabetes
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Sleep Disorder
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Remote Patient Monitoring Software And Services Market, By End- Use
10.1. Remote Patient Monitoring Software And Services Market, by End- Use, 2022-2030
10.1.1. Patients
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Providers
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Remote Patient Monitoring Software And Services Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End- Use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End- Use (2017-2030)
Chapter 12. Company Profiles
12.1. Medtronic Plc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GE Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Siemens Healthineers AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Philips Healthcare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Caretaker Medical
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. OMRON Healthcare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. BioIntelliSense
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers